Figure 6 from Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models

<p>High–fiber-purified diet, but not chow, modestly enhances ICB efficacy in a breast cancer mouse model. <b>A,</b> Mean tumor volumes (calculated as the total volume of all individual mammary tumors per mouse) of MMTV-PyMT mice fed the indicated diets, with or without anti–PD-1 treatment. <b>B,</b> Fraction of mice free of a single primary tumor larger than 2,000 mm<sup>3</sup>. For <b>A</b> and <b>B</b>, <i>n</i> = 5 for isotype control and <i>n</i> = 10 for anti–PD-1 groups. <b>C</b> and <b>D,</b> Percentage of neutrophils and B cells among CD45<sup>+</sup> cells in primary tumors collected at endpoint. <i>n</i> = 6 to 8 tumors collected from five mice for no treatment and 10 to 12 tumors from nine mice for anti–PD-1. *, <i>P</i> < 0.05. The log-rank test for <b>B</b> and an ANOVA with the Tukey <i>post hoc</i> test for other panels. Values are mean ± SEM.</p>

Authors

Publication Details

Published
2025-09-02
DOI
https://doi.org/10.1158/0008-5472.30029890
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Figure 6 from Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models

Zihong Chen, Eric G. Pamer, Asael Roichman, Victoria Burgo et al.
Esophageal Cancer Research and Treatment
article

Figure 6 from Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models

Zihong Chen, Eric G. Pamer, Asael Roichman, Victoria Burgo, Yibin Kang, Michael R. MacArthur, Joshua D. Rabinowitz, Yong Wei, Akshada Sawant, Ziqing Chen, Gabriela Reyes‐Castellanos, Eileen White, Sarah J. Mitchell, Beianka Tomlinson, Xincheng Xu, Maria Gomez-Jenkins, Jesse R. Powers, Xiang Hang, Maria Ibrahim, Llewelyn Levett
article en

Abstract

<p>High–fiber-purified diet, but not chow, modestly enhances ICB efficacy in a breast cancer mouse model. <b>A,</b> Mean tumor volumes (calculated as the total volume of all individual mammary tumors per mouse) of MMTV-PyMT mice fed the indicated diets, with or without anti–PD-1 treatment. <b>B,</b> Fraction of mice free of a single primary tumor larger than 2,000 mm<sup>3</sup>. For <b>A</b> and <b>B</b>, <i>n</i> = 5 for isotype control and <i>n</i> = 10 for anti–PD-1 groups. <b>C</b> and <b>D,</b> Percentage of neutrophils and B cells among CD45<sup>+</sup> cells in primary tumors collected at endpoint. <i>n</i> = 6 to 8 tumors collected from five mice for no treatment and 10 to 12 tumors from nine mice for anti–PD-1. *, <i>P</i> < 0.05. The log-rank test for <b>B</b> and an ANOVA with the Tukey <i>post hoc</i> test for other panels. Values are mean ± SEM.</p>

Openalex Percentile: Top 63%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.